Observational study of the acceptability of Sayana® Press among intramuscular DMPA users in Uganda and Senegal.

@article{Burke2014ObservationalSO,
  title={Observational study of the acceptability of Sayana® Press among intramuscular DMPA users in Uganda and Senegal.},
  author={Holly McClain Burke and Monique Peloquin Mueller and Brian C Perry and Catherine A Packer and Leonard Bufumbo and Daouda Mbengue and Ibrahima Mall and Bocar Mamadou Daff and Anthony Kabanza Mbonye},
  journal={Contraception},
  year={2014},
  volume={89 5},
  pages={361-7}
}
BACKGROUND Sayana® Press (SP), a subcutaneous formulation of depot medroxyprogesterone acetate (DMPA) in Uniject™, has potential to be a valuable innovation in family planning (FP) because it may overcome logistic and safety challenges in delivering intramuscular DMPA (DMPA IM). However, SP's acceptability is unknown. We measured acceptability of SP among DMPA IM users. STUDY DESIGN This open-label observational study was conducted in clinics in three districts in Senegal and community-based… CONTINUE READING